Skip to content
The Great News – Lifestyle
Home
Sample Page
Author:
Silexion Therapeutics Corp
Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
March 24, 2026
Silexion Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
March 17, 2026
←
Previous Page
1
2